Exane Derivatives’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $509 | Hold |
180
| – | – | ﹤0.01% | 568 |
|
|
2022
Q1 | $751 | Hold |
180
| – | – | ﹤0.01% | 828 |
|
|
2021
Q4 | $934 | Hold |
180
| – | – | ﹤0.01% | 705 |
|
|
2021
Q3 | $1.18K | Hold |
180
| – | – | ﹤0.01% | 823 |
|
|
2021
Q2 | $1.14K | Hold |
180
| – | – | ﹤0.01% | 842 |
|
|
2021
Q1 | $1.03K | Hold |
180
| – | – | ﹤0.01% | 713 |
|
|
2020
Q4 | $1.61K | Hold |
180
| – | – | ﹤0.01% | 630 |
|
|
2020
Q3 | $2.1K | Hold |
180
| – | – | ﹤0.01% | 534 |
|
|
2020
Q2 | $2.89K | Hold |
180
| – | – | ﹤0.01% | 461 |
|
|
2020
Q1 | $1.08K | Hold |
180
| – | – | ﹤0.01% | 516 |
|
|
2019
Q4 | $2.29K | Sell |
180
-2,908
| -94% | -$37K | ﹤0.01% | 465 |
|
|
2019
Q3 | $38.3K | Hold |
3,088
| – | – | 0.01% | 362 |
|
|
2019
Q2 | $49.7K | Buy |
+3,088
| New | +$49.7K | 0.01% | 372 |
|